| Cash Flow | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Net (loss) income | -582,600 | 129,200 | 64,500 | 211,100 |
| Depreciation and amortization | 306,900 | 202,400 | 99,700 | 304,600 |
| Impairment charges | 785,000 | - | - | 0 |
| Stock-based compensation expense | 35,100 | 27,900 | 12,400 | 35,700 |
| Non-cash restructuring charges (see note 8) | 0 | - | - | 16,400 |
| Provision for accounts receivable and inventory | 43,400 | 26,900 | 12,000 | 55,800 |
| Deferred income tax benefit | -41,900 | -30,000 | -12,400 | -75,300 |
| Amortization of deferred financing costs | 6,600 | 4,500 | 2,200 | 8,600 |
| Loss on extinguishment of debt | -200 | 0 | 0 | -6,500 |
| Foreign currency remeasurement loss | -700 | -3,800 | -1,900 | -3,000 |
| Pension termination charges | 18,100 | 18,100 | 18,100 | - |
| Accounts receivable | -10,500 | 55,700 | 43,200 | -34,200 |
| Inventory | 66,700 | 33,300 | 17,600 | 21,500 |
| Accounts payable | -4,400 | 19,100 | 8,200 | 41,900 |
| Accrued interest | -13,400 | 1,400 | -9,300 | -16,500 |
| Other assets and liabilities | 27,400 | 52,900 | 29,100 | -63,000 |
| Other | -1,000 | -2,300 | -1,900 | 0 |
| Net cash provided by operating activities | 471,100 | 263,700 | 109,300 | 667,500 |
| Capital expenditures | 93,300 | 57,600 | 28,000 | 121,300 |
| Other | -2,500 | -100 | 900 | -1,700 |
| Net cash used in investing activities | -90,800 | -57,500 | -28,900 | -119,600 |
| Debt borrowings | 67,700 | 0 | 0 | - |
| Debt repayments | 477,300 | 38,100 | 31,300 | 585,000 |
| Payments of debt refinancing fees and premiums | - | - | - | 0 |
| Proceeds received from exercise of stock options | 4,900 | 2,600 | 2,600 | 67,300 |
| Shares repurchased to satisfy employee tax obligations for vested stock-based awards | -5,400 | -5,000 | -4,900 | -8,200 |
| Net cash used in financing activities | -410,100 | -40,500 | -33,600 | -525,900 |
| Effect of currency rate changes on cash and cash equivalents | 19,800 | 21,800 | 7,000 | 600 |
| Net change in cash, cash equivalents and restricted cash | -10,000 | 187,500 | 53,800 | 22,600 |
| Cash and cash equivalents at beginning of period | 264,700 | 264,700 | 264,700 | 287,700 |
| Cash and cash equivalents at end of period | 254,700 | 452,200 | 318,500 | 310,300 |
Avantor, Inc. (AVTR)
Avantor, Inc. (AVTR)